Copyright
©The Author(s) 2017.
World J Cardiol. Jun 26, 2017; 9(6): 481-495
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.481
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.481
Class of indication | Guideline | Differences between guidelines | |
ESC/ EACTS 2012 | AHA/ACC 2016 Consensus on AHA/ACC 2014, and ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM 2010 Guidelines | ||
I | - | Asymptomatic bicuspid aortic valve with dilatation of Valsalva sinuses or the ascending thoracic aortic diameter > 55 mm | No class I indications in the 2012 ESC/EACTS guidelines |
IIa | Bicuspid aortic valve with an ascending thoracic aortic diameter > 50 mm if the patient also has at least one of the followings: Family history of aortic dissection; documented increase in the aortic diameter > 2 mm/yr (assessed using the same imaging method, at the same level, and with comparative images available); arterial hypertension; coarctation of the aorta | Bicuspid aortic valve AND dilatation of the Valsalva sinuses or of the ascending thoracic aorta (> 50 mm) AND at least one of the following | |
Family history of aortic dissection | |||
Documented increase in aortic diameter > 5 mm/yr | |||
OR low surgical risk in an expert center | |||
- | Replacement of the ascending aorta if the patient also has an indication for surgery for AS/AR, and the ascending aortic/Valsalva sinus diameter is > 45 mm | Not covered by the 2012 ESC guidelines |
- Citation: Mǎrgulescu AD. Assessment of aortic valve disease - a clinician oriented review. World J Cardiol 2017; 9(6): 481-495
- URL: https://www.wjgnet.com/1949-8462/full/v9/i6/481.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i6.481